Can Neutrophil‐to‐Lymphocyte Ratio, Monocyte‐to‐Lymphocyte Ratio, and Platelet‐to‐Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?
- Published in:
- Clinical Transplantation, 2018, v. 32, n. 9, p. 1, doi. 10.1111/ctr.13359
- By:
- Publication type:
- Article